v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Operating activities    
Net income (loss) $ 499 $ (30,409)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 26,409 16,341
Amortization of intangible assets 4,174 4,088
Amortization of deferred contract acquisition costs 55,322 37,592
Non-cash operating lease cost 3,092 2,237
Stock-based compensation expense 130,856 102,494
Deferred income taxes (255) 1,752
Non-cash interest expense 754 669
Change in fair value of strategic investments 0 (2,208)
Changes in operating assets and liabilities, net of impact of acquisitions    
Accounts receivable, net 165,089 (1,058)
Deferred contract acquisition costs (49,532) (51,354)
Prepaid expenses and other assets (8,542) 4,243
Accounts payable (18,596) (36,431)
Accrued expenses and other liabilities (36,576) (7,300)
Accrued payroll and benefits (17,281) 13,235
Operating lease liabilities (3,199) (2,210)
Deferred revenue 48,678 163,276
Net cash provided by operating activities 300,892 214,957
Investing activities    
Purchases of property and equipment (62,264) (52,211)
Capitalized internal-use software and website development costs (10,902) (5,214)
Purchases of strategic investments (10,513) (2,825)
Purchases of intangible assets 0 (700)
Proceeds from sales of investments 150,000 0
Purchases of deferred compensation investments (290) 0
Net cash provided by (used in) investing activities 66,031 (60,950)
Financing activities    
Proceeds from issuance of common stock upon exercise of stock options 2,651 3,106
Capital contributions from non-controlling interest holders 5,257 1,462
Net cash provided by financing activities 7,908 4,568
Effect of foreign exchange rates on cash, cash equivalents and restricted cash (190) (2,472)
Net increase in cash, cash equivalents and restricted cash 374,641 156,103
Cash, cash equivalents and restricted cash at beginning of period 2,456,924 1,996,633
Cash, cash equivalents and restricted cash at end of period 2,831,565 2,152,736
Cash and cash equivalents 2,829,677 2,152,736
Restricted cash included in prepaid expenses and other assets 1,888 0
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 2,831,565 2,152,736
Supplemental disclosure of cash flow information:    
Interest paid 11,250 11,265
Income taxes paid, net of refunds received 3,377 3,948
Supplemental disclosure of non-cash investing and financing activities:    
Net increase (decrease) in property and equipment included in accounts payable and accrued expenses (22,479) 13,165
Vesting of early exercised stock options 0 735
Operating lease liabilities arising from obtaining operating right of-use assets 13,847 0
Purchases of intangible assets included in accrued expenses and other liabilities $ 500 $ 0